Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:23 am Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 9,424,074 6.390% | -3,382,439 (-26.41%) | Filing History |
| 2025-02-13 2:20 pm Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Nikko Asset Management Americas, Inc. | 6,833,137 4.630% | -900,747 (-11.65%) | Filing History |
| 2025-02-04 06:13 am Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Sumitomo Mitsui Trust Group Inc. | 6,833,137 4.600% | -900,747 (-11.65%) | Filing History |
| 2025-01-27 4:00 pm Sale | 2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 6,292,634 4.300% | -3,107,939 (-33.06%) | Filing History |
| 2024-11-13 4:30 pm Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Rubric Capital Management LP | 14,400,000 9.760% | 14,400,000 (New Position) | Filing History |
| 2024-11-13 09:00 am Sale | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Matrix Capital Management Company LP | 650,000 0.440% | -10,922,590 (-94.38%) | Filing History |
| 2024-11-12 1:30 pm Unchanged | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | VANGUARD GROUP INC | 10,639,440 7.210% | 0 (Unchanged) | Filing History |
| 2024-11-08 3:15 pm Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Nikko Asset Management Americas, Inc. | 7,733,884 5.240% | 7,733,884 (New Position) | Filing History |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Sumitomo Mitsui Trust Group Inc. | 7,733,884 5.240% | 7,733,884 (New Position) | Filing History |
| 2024-11-04 10:58 am Sale | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | VANGUARD GROUP INC | 10,639,440 7.210% | -2,128,244 (-16.67%) | Filing History |
| 2024-10-11 4:14 pm Purchase | 2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 9,400,573 6.400% | 1,650,440 (+21.30%) | Filing History |
| 2024-05-28 4:22 pm Purchase | 2024-05-17 | 13G | Adaptive Biotechnologies Corporation ADPT | Integrated Core Strategies (US) LLC | 7,750,133 5.300% | 7,750,133 (New Position) | Filing History |
| 2024-02-14 10:23 am Unchanged | 2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 20.700% | 0 (Unchanged) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Adaptive Biotechnologies Corporation ADPT | VANGUARD GROUP INC | 12,767,684 8.820% | 973,516 (+8.25%) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 12,806,513 8.850% | 3,605,268 (+39.18%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | BlackRock Inc. BLK | 11,421,554 7.900% | -952,643 (-7.70%) | Filing History |
| 2023-02-13 3:52 pm Purchase | 2022-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | BlackRock Inc. BLK | 12,374,197 8.700% | 12,374,197 (New Position) | Filing History |
| 2023-02-10 10:25 am Purchase | 2022-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | ARK Investment Management LLC | 9,201,245 6.430% | 9,201,245 (New Position) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | Adaptive Biotechnologies Corporation ADPT | VANGUARD GROUP INC | 11,794,168 8.250% | 762,880 (+6.92%) | Filing History |
| 2022-09-12 2:07 pm Sale | 2022-08-31 | 13G | Adaptive Biotechnologies Corporation ADPT | T. Rowe Price Associates, Inc. | 4,081,518 2.900% | -10,159,096 (-71.34%) | Filing History |